For Breast Cancer Awareness Month, Oranus Mohammadi, MD, discussed the remarkable progress made in improving survival rates for patients with breast cancer.
The Oncology Institute
Latest Content
Treatment with the investigational Bruton’s tyrosine kinase inhibitor, pirtobrutinib, will be compared with ibrutinib treatment in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma in a phase 2 study.
A publicly traded leader in value-based oncology care raises standards in patient safety.
An executive announcement from the Oncology of Hope and Innovation Institute.
The Oncology Institute Expands into South Florida
Published: | Updated:
Two new TOI-affiliated oncology practices have open in South Florida.
The Oncology Institute Appoints Two New Board Members
Published: | Updated:
The Oncology InstituteeExpands board to 9 members with deep healthcare management and investment experience.
The Oncology Institute Partners with Blue Note Therapeutics to Provide a Digital Therapeutic for Treating Cancer-related Anxiety and Depression Symptoms
Published: | Updated:
The Oncology Institute, Inc ave partnered to provide enhanced psychological support services for TOI patients.